心不全ソフトウェア市場：タイプ別、疾患タイプ別、プラットフォーム別、アプリケーション別、エンドユーザー別、展開モデル別-2025-2030年の世界予測

心不全ソフトウェア市場は、2024年には24億7,000万米ドルとなり、2025年には26億5,000万米ドル、CAGR 7.18%で成長し、2030年には37億5,000万米ドルに達すると予測されています。

心不全は、現代医療における最も複雑で差し迫った課題の1つであり、専用のソフトウェアソリューションの登場により、臨床医、研究者、管理者がこの疾患を管理する方法が再構築され始めています。心不全ソフトウェアの進化は単なる技術革新の機能ではなく、ケア提供、データ統合、積極的な患者管理におけるパラダイムシフトを意味しています。デジタルヘルスにおける最新の進歩を活用することに重点を置いたこの市場は、診断精度の向上、臨床ワークフローの合理化、リアルタイムモニタリングが患者の転帰を改善するために融合する、ソリューションであり戦略でもあります。

従来の紙ベースのシステムから洗練されたアルゴリズム主導のプラットフォームへの移行は、ヘルスケアの状況に大きな変化をもたらしました。業界がデジタルツールの急速な導入を目の当たりにする中、バリューチェーン全体の利害関係者は、サービス提供、リソース配分、臨床意思決定へのアプローチを見直す必要に迫られています。本エグゼクティブサマリーでは、心不全ソフトウェアの背後にある変革の力について掘り下げ、心不全のモニタリングと管理の方法に革命をもたらしつつある革新的なセグメント、地域ダイナミクス、企業戦略を探る。この後の考察は、この進化する市場のマクロ動向とミクロの詳細の両方を把握したい実務者、意思決定者、専門家向けに作成されています。

変革の触媒としての心不全ソフトウェアにおける変革的シフト

近年、心不全ソフトウェア市場は、臨床とヘルスケアエコシステムの双方を再定義する一連の変革的シフトを経験しています。先駆的なソフトウェア・ソリューションは現在、高度なデータ分析プラットフォームとの統合、予測モデリングの促進、リアルタイムの遠隔モニタリング機能を提供しています。このような進化は単独で起こっているのではなく、患者の転帰の改善、病院再入院の減少、臨床意思決定支援の強化の必要性に後押しされ、ヘルスケアにおけるデジタルトランスフォーメーションに向けた大きなトレンドの一部となっています。

デジタルヘルス技術は、コミュニケーションギャップを埋め、プロセスを合理化し、包括的なデータセットに基づく実用的な洞察を臨床医に提供する上で役立っています。さらに、規制の更新と価値に基づくケアへの関心の高まりが、リスク層別化と予測分析をサポートする革新的なソフトウェアへの投資に拍車をかけています。臨床システム間の相互運用性を目指す動きは、心不全ソフトウェアと患者の電子記録の統合を可能にし、診断のスピードと精度を向上させています。その結果、ヘルスケアプロバイダーは、患者の治療をプロアクティブに管理し、治療計画を迅速に調整し、最終的には、よりテーラーメイドの治療介入を提供できるようになりました。

クラウドベースのソリューション、モバイル技術、データ主導型アナリティクスの継続的な融合は、心不全市場における成長と差別化のための大きな機会を生み出しています。医療現場全体がこれらの最先端ツールに投資しているため、心不全ソフトウェアがもたらす変革的影響は今後も続き、技術は心臓治療の将来における基盤的要素として位置づけられると思われます。

市場戦略を推進する主要セグメンテーションの洞察

詳細な調査により、心不全ソフトウェア市場は、各セグメントが独自の機会と課題を提供する、微妙なセグメンテーションアプローチを通じて理解できることが明らかになりました。タイプ別に評価すると、市場は知識ベースと非知識ベースの分類で区別され、より一般化されたデータ中心のアプローチではなく、エキスパートシステムや臨床アルゴリズムを活用することの重要性が強調されます。さらに、疾患タイプによるセグメンテーションも重要であり、先天性心不全、左心不全、右心不全が含まれます。各カテゴリーでは、特定の臨床ニーズを満たすために、独自の戦略とカスタマイズされた機能が求められます。

さらにプラットフォーム別に分類すると、統合型ソリューションとスタンドアロン型ソリューションがあります。統合型システムは、既存の電子カルテとのシームレスな相互運用性が利点であり、スタンドアロン型ソリューションは、大規模なインフラ統合を必要としない柔軟性と迅速な展開を提供します。分析はアプリケーション分野にも及び、臨床意思決定支援、データ分析、電子カルテ統合、モバイル＆患者中心アプリケーション、予測分析＆リスク層別化ツール、遠隔モニタリング＆遠隔医療プラットフォームなどの機能が含まれます。広範なアプリケーションは、心不全ソフトウェアの多用途性を強調するだけでなく、心不全ソフトウェアが対処する多様な臨床課題も示しています。

もう1つの重要なセグメンテーションはエンドユーザーに基づくもので、市場は診療所、在宅医療、病院などさまざまな環境に対応しています。最後に、クラウドベースのシステム、オンプレミス、ウェブベースのオプションを含む展開モデルのセグメンテーションは、さまざまな組織のニーズや技術的能力に対応するために必要な柔軟性を示しています。このような階層的なセグメンテーションの枠組みは、提供する製品をカスタマイズし、リソース配分を最適化し、革新的なソフトウェアソリューションが多様なヘルスケア環境の具体的な要求に確実に応えることを目指す市場関係者にとって不可欠です。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で高齢化社会における心不全の罹患率が上昇しており、専門的なソフトウェアソリューションの需要が高まっています。
    • 心不全管理における遠隔患者モニタリングと遠隔医療の統合の増加
    • ヘルスケアITと患者ケアシステムの革新を促進する規制支援と政府のインセンティブの拡大
  • 抑制要因
    • 心不全ソフトウェアの開発と実装に関連する高コストが採用に影響
  • 機会
    • 革新的なソリューションを開発するために、ヘルスケア提供者とテクノロジー企業間の連携を強化する
    • アクセシビリティとスケーラビリティを向上させる人工知能ベースの心不全ソフトウェアの潜在能力の拡大
  • 課題
    • 心不全ソフトウェアに関連するデータセキュリティとプライバシーに関する懸念
• 市場セグメンテーション分析
  • タイプ：高度な分析を活用した知識ベースプラットフォームの重要性の高まり
  • 疾患の種類：先天性心不全患者が世界中で増加し、心不全ソフトウェアの需要が高まっている
  • プラットフォーム：より広範な臨床情報システムとシームレスに連携する統合プラットフォームの重要性が高まっています。
  • 応用：治療効果に関するデータ分析の継続的な進歩
  • エンドユーザー：在宅ケアの現場での心不全ソフトウェアの採用増加
  • 導入モデル：プライバシーへの懸念からオンプレミスモデルへの好みが移行
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 心不全ソフトウェア市場：タイプ別

• 知識ベース
• 非知識ベース

第7章 心不全ソフトウェア市場：疾患タイプ別

• 先天性心不全
• 左心不全
• 右心不全

第8章 心不全ソフトウェア市場：プラットフォーム別

• 統合型
• スタンドアロン

第9章 心不全ソフトウェア市場：用途別

• 臨床意思決定支援
• データ分析
• 電子医療記録の統合
• モバイルおよび患者中心のアプリケーション
• 予測分析とリスク層別化ツール
• 遠隔モニタリングと遠隔医療プラットフォーム

第10章 心不全ソフトウェア市場：エンドユーザー別

• クリニック
• 在宅ケア設定
• 病院

第11章 心不全ソフトウェア市場展開モデル別

• クラウドベースのシステム
• オンプレミス
• ウェブベース

第12章 南北アメリカの心不全ソフトウェア市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第13章 アジア太平洋地域の心不全ソフトウェア市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第14章 欧州・中東・アフリカの心不全ソフトウェア市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第15章 競合情勢

• 市場シェア分析, 2024
• FPNVポジショニングマトリックス, 2024
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AliveCor, Inc.
• Astellas Pharma Inc.
• Axis Clinical Software, Inc.
• Biofourmis Inc.
• Biome.io
• BIOPAC Systems Inc.
• Boston Scientific Corporation
• Canon Medical Systems Corporation
• Cardiac RMS, LLC by DocGo, Inc.
• CitiusTech Inc.
• Cleerly, Inc.
• CV Medical Software
• Dyad Medical Inc.
• Eko Health Inc.
• Elucid Bioimaging Inc.
• Endotronix, Inc
• Epic Systems Corporation
• Foundry Innovation & Research 1 Ltd.
• GE HealthCare Technologies Inc.
• Heart Input Output Inc.
• Implicity
• International Business Machines Corporation
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• Medtronic PLC
• N. Harris Computer Corporation
• NorthEast Monitoring, Inc.
• Oracle Corporation
• PaceMate, LLC
• Pacertool AS
• Precordior Ltd.
• Siemens AG
• Ultromics Limited
• VectraCor Inc.
• VUNO Inc.
• ZOLL Medical Corporation

LIST OF FIGURES

• FIGURE 1. HEART FAILURE SOFTWARE MARKET MULTI-CURRENCY
• FIGURE 2. HEART FAILURE SOFTWARE MARKET MULTI-LANGUAGE
• FIGURE 3. HEART FAILURE SOFTWARE MARKET RESEARCH PROCESS
• FIGURE 4. HEART FAILURE SOFTWARE MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2030 (%)
• FIGURE 19. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 21. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 23. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 27. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 28. HEART FAILURE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 29. HEART FAILURE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HEART FAILURE SOFTWARE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HEART FAILURE SOFTWARE MARKET DYNAMICS
• TABLE 7. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY KNOWLEDGE BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY NON-KNOWLEDGE BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CONGENITAL HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY LEFT-SIDED HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY RIGHT-SIDED HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY INTEGRATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY STANDALONE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DATA ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ELECTRONIC MEDICAL RECORD INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY MOBILE & PATIENT-CENTRIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY PREDICTIVE ANALYTICS & RISK STRATIFICATION TOOLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY REMOTE MONITORING & TELEHEALTH PLATFORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY CLOUD-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL HEART FAILURE SOFTWARE MARKET SIZE, BY WEB-BASED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 51. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 54. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CANADA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES HEART FAILURE SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 83. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 86. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. CHINA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 89. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 92. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. INDIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 192. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 195. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. ITALY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 216. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 218. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 219. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. POLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 222. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 223. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 224. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 225. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. QATAR HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY PLATFORM, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM HEART FAILURE SOFTWARE MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2030 (USD MILLION)
• TABLE 282. HEART FAILURE SOFTWARE MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 283. HEART FAILURE SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2024

The Heart Failure Software Market was valued at USD 2.47 billion in 2024 and is projected to grow to USD 2.65 billion in 2025, with a CAGR of 7.18%, reaching USD 3.75 billion by 2030.

Heart failure remains one of the most complex and pressing challenges in modern healthcare, and the advent of dedicated software solutions has begun to reshape the way clinicians, researchers, and administrators manage this condition. The evolution of heart failure software is not merely a function of technological innovation; it represents a paradigm shift in care delivery, data integration, and proactive patient management. With a focus on harnessing the latest advancements in digital health, this market is emerging as both a solution and a strategy, where improved diagnostic accuracy, streamlined clinical workflows, and real-time monitoring converge to improve patient outcomes.

The progression from traditional, paper-based systems to sophisticated, algorithm-driven platforms has triggered significant changes in the healthcare landscape. As the industry witnesses rapid adoption of digital tools, stakeholders from across the value chain are compelled to reassess their approaches to service delivery, resource allocation, and clinical decision-making. This executive summary delves into the transformative forces behind heart failure software, exploring innovative segments, regional dynamics, and company strategies that are revolutionizing the way heart failure is monitored and managed. The discussion that follows is designed for practitioners, decision-makers, and experts looking to grasp both the macro trends and micro details of this evolving market.

Transformative Shifts in Heart Failure Software as a Catalyst for Change

In recent years, the heart failure software market has experienced a series of transformative shifts that are redefining both clinical practices and the broader healthcare ecosystem. Pioneering software solutions are now capable of integrating with advanced data analytics platforms, facilitating predictive modeling, and offering real-time remote monitoring capabilities. This evolution is not occurring in isolation but is part of a larger trend towards digital transformation in healthcare, driven by the need for improved patient outcomes, reduced hospital readmissions, and enhanced clinical decision support.

Digital health technologies have been instrumental in bridging communication gaps, streamlining processes, and providing clinicians with actionable insights based on comprehensive data sets. Furthermore, regulatory updates and an increased focus on value-based care have spurred investments in innovative software that supports risk stratification and predictive analytics. The move towards interoperability among clinical systems has enabled the integration of heart failure software with patient electronic records, thereby improving the speed and accuracy of diagnoses. As a result, healthcare providers are better equipped to manage patient care proactively, adjust treatment plans swiftly, and ultimately, deliver more tailored therapeutic interventions.

The ongoing convergence of cloud-based solutions, mobile technology, and data-driven analytics is generating substantial opportunities for growth and differentiation in the heart failure market. As organizations across the medical landscape invest in these cutting-edge tools, the transformative impact of heart failure software is set to continue, positioning technology as a foundational element in the future of cardiac care.

Key Segmentation Insights Driving Market Strategy

A detailed examination reveals that the heart failure software market can be understood through a nuanced segmentation approach, with each segment offering unique opportunities and challenges. When evaluated based on type, the market distinguishes between Knowledge Based and Non-Knowledge Based classifications, highlighting the importance of leveraging expert systems and clinical algorithms versus more generalized, data-centric approaches. Additionally, segmentation according to disease type has been instrumental, encompassing Congenital Heart Failure, Left-Sided Heart Failure, and Right-Sided Heart Failure; each category demands distinct strategies and tailored functionalities to meet specific clinical needs.

Further segmentation by platform distinguishes between Integrated and Standalone solutions. Integrated systems offer the advantage of seamless interoperability with existing electronic medical records, while standalone solutions provide flexibility and rapid deployment without extensive infrastructure integration. The analysis extends into application areas, which include functions such as Clinical Decision Support, Data Analytics, Electronic Medical Record Integration, Mobile & Patient-centric Applications, Predictive Analytics & Risk Stratification Tools, and Remote Monitoring & Telehealth Platforms. The broad spectrum of applications not only underscores the versatility of heart failure software but also the diverse clinical challenges it addresses.

Another crucial segmentation dimension is based on end-user, where the market caters to varied settings including Clinics, Homecare Settings, and Hospitals. Lastly, the deployment model segmentation, which encompasses Cloud-Based Systems, On-Premises, and Web-Based options, demonstrates the flexibility necessary to accommodate varying organizational needs and technological capabilities. This layered segmentation framework is essential for market players looking to tailor their offerings, optimize resource allocation, and ensure that innovative software solutions meet the specific demands of diverse healthcare environments.

Based on Type, market is studied across Knowledge Based and Non-Knowledge Based.

Based on Disease Type, market is studied across Congenital Heart Failure, Left-Sided Heart Failure, and Right-Sided Heart Failure.

Based on Platform, market is studied across Integrated and Standalone.

Based on Application, market is studied across Clinical Decision Support, Data Analytics, Electronic Medical Record Integration, Mobile & Patient-centric Applications, Predictive Analytics & Risk Stratification Tools, and Remote Monitoring & Telehealth Platform.

Based on End-User, market is studied across Clinics, Homecare Settings, and Hospitals.

Based on Deployment Model, market is studied across Cloud-Based Systems, On-Premises, and Web-Based.

Regional Dynamics Shaping the Heart Failure Software Market

A geographic analysis of the heart failure software market reveals that regional dynamics are playing an increasingly significant role in shaping market evolution and influencing product adoption. In the Americas, robust healthcare infrastructures combined with progressive regulatory frameworks have nurtured an environment ripe for digital health innovations. The emphasis on integrating advanced analytics with clinical decision support in this region is indicative of a broader commitment to value-based healthcare.

In markets spanning Europe, the Middle East, and Africa, a combination of government-driven health initiatives and growing private investment has sparked an impressive momentum within the sector. Market developments are largely influenced by the necessity to enhance patient management, streamline data flow, and promote interoperability among clinical systems. Concurrently, the Asia-Pacific region stands out due to its blend of emerging economies and rapidly modernizing healthcare infrastructure. This region is witnessing accelerated digital adoption, underpinned by a rising middle class, increased prevalence of cardiovascular diseases, and substantial investments in healthcare technology. The convergence of these regional insights provides a comprehensive picture of how local trends, economic factors, and healthcare policies collectively influence both the development and dissemination of heart failure software technologies.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Strategic Company Overview in the Heart Failure Software Domain

The competitive landscape in the heart failure software market is characterized by a blend of established multinational corporations and nimble innovators, each contributing distinct capabilities and strategic visions. Leading companies such as Abbott Laboratories, AliveCor, Inc., and Astellas Pharma Inc. have set benchmarks in integrating sophisticated diagnostic tools with robust software platforms. Other pioneering enterprises including Axis Clinical Software, Inc., Biofourmis Inc., and Biome.io are pushing the boundaries of what is possible by combining real-time data analytics with user-centric application designs.

Furthermore, trailblazers like BIOPAC Systems Inc. and Boston Scientific Corporation are leveraging their clinical expertise to embed advanced monitoring and diagnostic functionalities into their platforms. Canon Medical Systems Corporation and Cardiac RMS, LLC by DocGo, Inc. have achieved significant milestones by focusing on system interoperability and seamless integration with electronic medical records. It is equally noteworthy that CitiusTech Inc., Cleerly, Inc., and CV Medical Software continue to drive innovation through their state-of-the-art predictive analytics and remote monitoring solutions.

Other influential market players, including Dyad Medical Inc., Eko Health Inc., Elucid Bioimaging Inc., and Endotronix, Inc., are bolstering the market with specialized services that address specific clinical challenges. Not to be overlooked, organizations such as Epic Systems Corporation, Foundry Innovation & Research 1 Ltd., and GE HealthCare Technologies Inc. have further solidified their positions by facilitating improved data-driven decision making. This diverse assemblage of companies, which also includes Heart Input Output Inc., Implicity, International Business Machines Corporation, and iRhythm Technologies, Inc., exemplifies the competitive dynamism that is driving innovation in heart failure software. Koninklijke Philips N.V., Medtronic PLC, N. Harris Computer Corporation, NorthEast Monitoring, Inc., Oracle Corporation, PaceMate, LLC, and Pacertool AS are equally pivotal, contributing to an ecosystem that is as multifaceted as it is competitive. Additional players such as Precordior Ltd., Siemens AG, Ultromics Limited, VectraCor Inc., VUNO Inc., and ZOLL Medical Corporation underscore the commitment to technological excellence and strategic market expansion within this dynamic industry.

The report delves into recent significant developments in the Heart Failure Software Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AliveCor, Inc., Astellas Pharma Inc., Axis Clinical Software, Inc., Biofourmis Inc., Biome.io, BIOPAC Systems Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardiac RMS, LLC by DocGo, Inc., CitiusTech Inc., Cleerly, Inc., CV Medical Software, Dyad Medical Inc., Eko Health Inc., Elucid Bioimaging Inc., Endotronix, Inc, Epic Systems Corporation, Foundry Innovation & Research 1 Ltd., GE HealthCare Technologies Inc., Heart Input Output Inc., Implicity, International Business Machines Corporation, iRhythm Technologies, Inc., Koninklijke Philips N.V., Medtronic PLC, N. Harris Computer Corporation, NorthEast Monitoring, Inc., Oracle Corporation, PaceMate, LLC, Pacertool AS, Precordior Ltd., Siemens AG, Ultromics Limited, VectraCor Inc., VUNO Inc., and ZOLL Medical Corporation. Actionable Recommendations for Industry Leaders

In order to secure a competitive edge in the rapidly evolving heart failure software market, industry leaders must adopt strategic measures that align with both current trends and future projections. It is essential that organizations invest in robust R&D capabilities to refine product functionalities and incorporate cutting-edge predictive analytics and risk stratification modules. Leaders should also explore opportunities to deepen their integration with existing healthcare IT infrastructures, thereby ensuring that their solutions offer seamless interoperability with electronic health records and other clinical systems.

Looking ahead, companies must emphasize agility in deployment models, particularly as the demand for cloud-based, on-premises, and web-based solutions shifts in response to regional and institutional preferences. Developing strategic partnerships with technology innovators and regulatory bodies can accelerate product development and market acceptance. Additionally, focusing on patient-centric applications and remote monitoring technologies is crucial, especially in an era where mobile health solutions and telehealth platforms continue to gain traction.

To further solidify their market position, industry players are encouraged to regularly engage with clinical experts and end-users, gathering valuable feedback that can inform iterative product improvements. Embracing a culture of continuous innovation, supported by proactive risk management and strategic forecasting, will enable companies to not only meet the current market demand but also anticipate emerging trends. Ultimately, a balanced strategy that integrates technical prowess with a deep understanding of clinical needs will be indispensable for sustained success in this competitive landscape.

Conclusion: Charting the Future of Heart Failure Software

The heart failure software market stands as a testament to the transformative potential of digital health solutions, where technology intersects with clinical expertise to drive meaningful improvements in patient care. As the industry continues to mature, a clear emphasis on data integration, real-time analytics, and patient-centric applications is paving the way for more effective disease management and enhanced clinical outcomes. Stakeholders across the board-from technology innovators and healthcare providers to strategic investors-face a landscape that is both rich with opportunity and fraught with the challenges of rapid technological change.

The multifaceted segmentation of the market underscores the importance of customized approaches to suit varied clinical needs and deployment environments. Regional trends further highlight the global demand for innovative software solutions that can adapt to diverse healthcare infrastructures and regulatory climates. Moreover, the competitive dynamics driven by both established giants and emerging trailblazers have set the stage for continuous evolution. As the market advances, the commitment to technological excellence and strategic market positioning will be essential in shaping the future of heart failure management.

In summary, the rapid convergence of clinical expertise, technological innovation, and strategic foresight presents a compelling case for sustained investment in heart failure software. The trajectory set by current trends not only highlights the immediate benefits of digital transformation in healthcare but also points to a future where data-driven insights lead to better health outcomes for millions of patients worldwide.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of heart failure among aging populations worldwide increases demand for specialized software solutions
    • 5.1.1.2. Rising integration of remote patient monitoring and telehealth in heart failure management
    • 5.1.1.3. Growing regulatory support and government incentives promoting innovation in healthcare IT and patient care systems
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with the development and implementation of heart failure software affect adoption
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing collaborations between healthcare providers and tech companies to develop innovative solutions
    • 5.1.3.2. Growing potential of artificial intelligence-based heart failure software for enhanced accessibility and scalability
  • 5.1.4. Challenges
    • 5.1.4.1. Data security and privacy concerns associated with heart failure software
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Rising significance of knowledge-based platform as it leverages advanced analytics
  • 5.2.2. Disease Type: Growing patients of congenital heart failure globally drives demand for heart failure software
  • 5.2.3. Platform: Increasing significance of integrated platforms to work seamlessly with broader clinical information systems
  • 5.2.4. Application: Ongoing advancements in data analytics for treatment efficacy
  • 5.2.5. End-User: Upsurge in adoption of heart failure software in homecare settings
  • 5.2.6. Deployment Model: Shifting preference towards on-premise models due to privacy concerns
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Failure Software Market, by Type

• 6.1. Introduction
• 6.2. Knowledge Based
• 6.3. Non-Knowledge Based

7. Heart Failure Software Market, by Disease Type

• 7.1. Introduction
• 7.2. Congenital Heart Failure
• 7.3. Left-Sided Heart Failure
• 7.4. Right-Sided Heart Failure

8. Heart Failure Software Market, by Platform

• 8.1. Introduction
• 8.2. Integrated
• 8.3. Standalone

9. Heart Failure Software Market, by Application

• 9.1. Introduction
• 9.2. Clinical Decision Support
• 9.3. Data Analytics
• 9.4. Electronic Medical Record Integration
• 9.5. Mobile & Patient-centric Applications
• 9.6. Predictive Analytics & Risk Stratification Tools
• 9.7. Remote Monitoring & Telehealth Platform

10. Heart Failure Software Market, by End-User

• 10.1. Introduction
• 10.2. Clinics
• 10.3. Homecare Settings
• 10.4. Hospitals

11. Heart Failure Software Market, by Deployment Model

• 11.1. Introduction
• 11.2. Cloud-Based Systems
• 11.3. On-Premises
• 11.4. Web-Based

12. Americas Heart Failure Software Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Heart Failure Software Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Heart Failure Software Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Biome analytics introduces an AI-powered heart failure performance module to reduce hospital readmissions
  • 15.3.2. FIRE1 secures USD 120 million financing to advance its Norm heart failure management system
  • 15.3.3. Astellas receives FDA Listing for DIGITIVA, a digital health innovation for heart failure management
  • 15.3.4. Viz.ai and Cleerly partner to enhance heart disease assessment through advanced AI technologies
  • 15.3.5. Philips launches a first-to-market integrated suite of AI-enabled cardiac solutions to enhance diagnostic precision,
  • 15.3.6. PaceMate acquired Medtronic's Paceart Optima system, to enhance comprehensive remote monitoring solutions
  • 15.3.7. Eko Health's FDA-cleared low EF AI transforms early heart failure screening
  • 15.3.8. CardioSignal secures USD 10 million Series A investment to advance noninvasive heart failure detection
  • 15.3.9. Ultromics partners with Pfizer to expedite FDA clearance of EchoGo Amyloidosis AI technology for early detection of cardiac amyloidosis
  • 15.3.10. Cleerly secures FDA 510(k) clearance for its AI-enhanced ischemia diagnostic solution, integrating advanced CCTA analysis and clinical research
• 15.4. Strategy Analysis & Recommendation
  • 15.4.1. Abbott Laboratories
  • 15.4.2. Astellas Pharma Inc.
  • 15.4.3. Medtronic PLC
  • 15.4.4. Ultromics Limited

Companies Mentioned

• 1. Abbott Laboratories
• 2. AliveCor, Inc.
• 3. Astellas Pharma Inc.
• 4. Axis Clinical Software, Inc.
• 5. Biofourmis Inc.
• 6. Biome.io
• 7. BIOPAC Systems Inc.
• 8. Boston Scientific Corporation
• 9. Canon Medical Systems Corporation
• 10. Cardiac RMS, LLC by DocGo, Inc.
• 11. CitiusTech Inc.
• 12. Cleerly, Inc.
• 13. CV Medical Software
• 14. Dyad Medical Inc.
• 15. Eko Health Inc.
• 16. Elucid Bioimaging Inc.
• 17. Endotronix, Inc
• 18. Epic Systems Corporation
• 19. Foundry Innovation & Research 1 Ltd.
• 20. GE HealthCare Technologies Inc.
• 21. Heart Input Output Inc.
• 22. Implicity
• 23. International Business Machines Corporation
• 24. iRhythm Technologies, Inc.
• 25. Koninklijke Philips N.V.
• 26. Medtronic PLC
• 27. N. Harris Computer Corporation
• 28. NorthEast Monitoring, Inc.
• 29. Oracle Corporation
• 30. PaceMate, LLC
• 31. Pacertool AS
• 32. Precordior Ltd.
• 33. Siemens AG
• 34. Ultromics Limited
• 35. VectraCor Inc.
• 36. VUNO Inc.
• 37. ZOLL Medical Corporation